Digestive system diseases exhibit high clinical incidence rates and complex pathogenesis, creating an urgent need for the development of safe and effective therapeutic agents. Hesperetin is a flavonoid compound widely presented in Rutaceae plants, and serves as the primary effective component of traditional Chinese medicines such as Chenpi (Citri Reticulatae Pericarpium), Zhiqiao (Aurantii Fructus) and Qingpi (Citri Reticulatae Pericarpium Viride) in preventing and treating digestive system dysfunction. Modern pharmacological studies have confirmed that hesperetin could exert potential therapeutic effects on digestive system diseases such as non-alcoholic fatty liver disease, liver fibrosis, ulcerative colitis, gastric cancer, and colorectal cancer through multiple pathways including inhibiting inflammatory responses, antioxidative stress, improving lipid metabolism, regulating intestinal flora, regulating mitochondrial autophagy, antitumor, etc. This article summarizes and analyzes the relevant research reports at home and abroad in the past 30 years, systematically reviews the pharmacological effects and molecular mechanisms of hesperetin in treatment of digestive system diseases, and provides theoretical basis and scientific reference for the development of new drugs and health products.
Key words
hesperetin
/
digestive system disorders
/
non-alcoholic fatty liver disease
/
liver injury
/
gastric cancer
/
colorectal cancer
/
ulcerative colitis
YAN Yulu, HUANG Feifei, QIU Simeng, LIU Xinya, LIU Zengyang, CHEN Tingting, JIANG Xinyu, GONG Puyang.
Research progress on pharmacological effects and mechanisms of hesperetin in prevention and treatment of digestive system diseases[J].
Chinese Traditional and Herbal Drugs,
2026
, 57
(11)
: 4457
-4466
.
DOI: 10.7501/j.issn.0253-2670.2026.11.031
Li H Q, Yuan Q X, Wang S S, et al. Role of S-palmitoylation in digestive system diseases [J]. Cell Death Discov, 2025, 11: 331. Zhou Z B, Zhou Y, Zhang Z Y, et al. Progress on the effects and underlying mechanisms of evodiamine in digestive system diseases, and its toxicity: A systematic review and Meta-analysis [J]. Phytomedicine, 2024, 132: 155851. 李富云, 周德来, 王春霞, 等. 党参治疗消化系统疾病的作用机制研究概述[J]. 中药材, 2026, 49(1): 272-277. 张颖, 谈燕清, 刘杰, 等. 青钱柳总三萜通过调节FXR介导的胆汁酸和脂质代谢途径改善高脂饮食诱导的小鼠代谢相关脂肪性肝病[J]. 中草药, 2026, 57(3): 949-967. 冯小丽, 王雨薇, 王爽, 等. 鞣花酸治疗溃疡性结肠炎的药理作用研究进展[J]. 现代药物与临床, 2025, 40(12): 3200-3205. Yao Y, Liu L, Duan X X, et al. Micro/nano motors treating of digestive system diseases [J]. J Nanobiotechnol, 2025, 23(1): 685. 万微, 常军, 朱笃, 等. 橙皮素及其衍生物抑制纤维化作用研究进展[J]. 中国药物警戒, 2022, 19(5): 579-584. Ji Z K, Deng W, Chen D, et al. Recent understanding of the mechanisms of the biological activities of hesperidin and hesperetin and their therapeutic effects on diseases [J]. Heliyon, 2024, 10(5): e26862. 巢同磊, 王欠欠. 橙皮素及其衍生物的药理作用研究进展[J]. 中草药, 2018, 49(14): 3446-3451. Zareei S, Boojar M M A, Amanlou M. Inhibition of liver alanine aminotransferase and aspartate aminotransferase by hesperidin and its aglycone hesperetin: An in vitro and in silico study [J]. Life Sci, 2017, 178: 49-55. Sohel M, Sultana H, Sultana T, et al. Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review [J]. Heliyon, 2022, 8(1): e08815. Song B C, Hao M H, Zhang S, et al. Comprehensive review of hesperetin: Advancements in pharmacokinetics, pharmacological effects, and novel formulations [J]. Fitoterapia, 2024, 179: 106206. Choi E J. Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice [J]. Life Sci, 2008, 82(21/22): 1059-1064. Song C, Wang Z X, Cao J, et al. Hesperetin alleviates aflatoxin B1 induced liver toxicity in mice: Modulating lipid peroxidation and ferritin autophagy [J]. Ecotoxicol Environ Saf, 2024, 284: 116854. Alotaibi K S, Elobeid M, Virk P, et al. Plausible effect of hesperetin and nano-hesperetin against bisphenol-a induced hepatoxicity in a rat model [J]. Arab J Chem, 2024, 17(2): 105563. Liao H J, Cai J, Zhang L F, et al. A novel acute lethal liver injury mouse model with visualization of NF-κB activity for treatment of severe acute liver injury [J]. Am J Transl Res, 2017, 9(3): 962-970. 吴小红, 郭彦, 刘晨风, 等. LPS/D-GalN诱导小鼠急性肝损伤模型的建立[J]. 中国实验动物学报, 2014, 22(3): 15-19. He Y T, Xia Z J, Yu D Q, et al. Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/D-galactosamine induced acute liver failure in mice [J]. Int Immunopharmacol, 2019, 68: 171-178. Yang Y S, Liu Y, Wang Y W, et al. Regulation of SIRT1 and its roles in inflammation [J]. Front Immunol, 2022, 13: 831168. Singh V, Ubaid S. Role of silent information regulator 1(SIRT1) in regulating oxidative stress and inflammation [J]. Inflammation, 2020, 43(5): 1589-1598. Wang S W, Wang W, Sheng H, et al. Hesperetin, a SIRT1 activator, inhibits hepatic inflammation via AMPK/ CREB pathway [J]. Int Immunopharmacol, 2020, 89: 107036. 中华医学会, 中华医学会杂志社, 中华医学会肝病分会药物性肝病学组, 等. 中国药物性肝损伤基层诊疗与管理指南(2024年) [J]. 中华全科医师杂志, 2024, 23(8): 813-830. 王存萍, 罗秋林, 沙玉茹, 等. 中药抗药源性肝损伤评价模型及作用机制研究进展[J]. 中草药, 2023, 54(17): 5796-5805. Tang W W, Chen Z Y, Zhang W L, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects [J]. Signal Transduct Target Ther, 2020, 5: 87. Zaafar D, Khalil H M A, Elnaggar R, et al. Protective role of hesperetin in sorafenib-induced hepato- and neurotoxicity in mice via modulating apoptotic pathways and mitochondrial reprogramming [J]. Life Sci, 2024, 336: 122295. Yan M Z, Huo Y Z, Yin S T, et al. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions [J]. Redox Biol, 2018, 17: 274-283. Ramachandran A, Akakpo J Y, Curry S C, et al. Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure [J]. Biochem Pharmacol, 2024, 228: 116056. Wan J Y, Kuang G, Zhang L, et al. Hesperetin attenuated acetaminophen-induced hepatotoxicity by inhibiting hepatocyte necrosis and apoptosis, oxidative stress and inflammatory response via upregulation of heme oxygenase-1 expression [J]. Int Immunopharmacol, 2020, 83: 106435. 田晓玲, 蒋佳佳, 张彧, 等. 中药多糖防治非酒精性脂肪性肝病作用机制研究进展[J]. 中草药, 2024, 55(17): 6016-6025. Li J Y, Hu W J, Li C J, et al. Recent advances in hawthorn (Crataegus L.) polysaccharides for prevention and treatment of non-alcoholic fatty liver disease (NAFLD): A review [J]. Int J Biol Macromol, 2026, 336: 149403. 付祎珑, 林益游, 刘福才, 等. 基于网络药理学和动物实验探讨橙皮素对非酒精性脂肪性肝病的保护作用[J]. 中成药, 2025, 47(9): 3116-3123. Li J D, Wang T Q, Liu P P, et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/Akt-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD [J]. Food Funct, 2021, 12(9): 3898-3918. 葛晶晶. 基于肠道菌群和肝脏代谢组学研究柑橘类黄酮对非酒精性脂肪肝病的保护作用[D]. 南昌: 南昌大学, 2022. Cha J Y, Cho Y S, Kim I, et al. Effect of hesperetin, a Citrus flavonoid, on the liver triacylglycerol content and phosphatidate phosphohydrolase activity in orotic acid-fed rats [J]. Plant Foods Hum Nutr, 2001, 56(4): 349-358. 杨冰清, 尹静亚, 王琦. 肝线粒体功能障碍在非酒精性脂肪性肝病发病中的作用机制[J]. 临床肝胆病杂志, 2024, 40(1): 147-150. Chen S W, Lu H F, Yin G L, et al. Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKα-Drp1/PINK1-Parkin signaling pathway [J]. Biochim Biophys Acta BBA Mol Cell Biol Lipds, 2025, 1870(1): 159570. Wu Y, Lin Y, Xu S, et al. Mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experiments [J]. Open Med, 2025, 20: 20251215. 罗娟, 楼迪栋, 肖巧巧, 等. 橙皮素通过Nrf2/HO-1信号通路对非酒精性脂肪肝体外模型氧化应激的保护作用[J]. 中国比较医学杂志, 2022, 32(6): 1-6. Li W, Cai Z N, Schindler F, et al. Hesperetin protects from palmitic-acid-induced lipotoxicity through the inhibition of glutaminolysis, mTORC1 signaling, and limited apoptosis [J]. J Agric Food Chem, 2025, 73(35): 21932-21946. Geng Y N, Wu Z M, Buist-Homan M, et al. Hesperetin protects against palmitate-induced cellular toxicity via induction of GRP78 in hepatocytes [J]. Toxicol Appl Pharmacol, 2020, 404: 115183. Mackowiak B, Fu Y J, Maccioni L, et al. Alcohol-associated liver disease [J]. J Clin Investig, 2024, 134(3): e176345. Seitz H K, Bataller R, Cortez-Pinto H, et al. Alcoholic liver disease [J]. Nat Rev Dis Primers, 2018, 4: 16. Yuan F, Xia G Q, Cai J N, et al. Hesperitin attenuates alcoholic steatohepatitis by regulating TLR4/NF-κB signaling in mice [J]. Anal Biochem, 2023, 682: 115339. 张卫东, 华丰, 赵权, 等. 橙皮素通过靶向线粒体调控肝细胞焦亡在缓解酒精性肝损伤中的作用及机制[J]. 中国中药杂志, 2026, 51(8): 2310-2322. 王琦, 王燕, 王光忠, 等. 麸炒苍术醇提物通过代谢调节缓解胆管结扎诱导小鼠肝纤维化作用[J]. 中草药, 2026, 57(5): 1742-1758. 程盛勇, 胡光线, 付志丽, 等. 橙皮素对四氯化碳诱导的肝纤维化小鼠的保护作用及机制[J]. 西部医学, 2026, 38(2): 201-206. Li X X, Xu J X, Ren Z K, et al. Hesperetin alleviates liver fibrosis by improving intestinal microbiota composition and regulating hepatic stellate cell autophagy [J]. Eur J Pharmacol, 2025, 1005: 178106. Kong R, Wang N, Luo H, et al. Hesperetin mitigates bile duct ligation-induced liver fibrosis by inhibiting extracellular matrix and cell apoptosis via the TGF-β1/ Smad pathway [J]. Curr Mol Med, 2018, 18(1): 15-24. 陈光煜. 橙皮素体外对人HepG2肝癌细胞生长及Caspase-3表达的影响[D]. 桂林: 桂林医学院, 2012. 赵文梅, 宁贻崇, 陈杉彬, 等. 橙皮素通过调控p53通路关键蛋白抑制肝癌细胞SMMC-7721增殖、迁移并诱导凋亡[J]. 毒理学杂志, 2025, 39(2): 132-138. 李晓媛, 郭昊翊, 郭敏娟, 等. 橙皮素通过Wnt/β-catenin信号通路调控肝癌细胞增殖、凋亡、侵袭和迁移的机制研究[J]. 中国免疫学杂志, 2022, 38(3): 348-352. Zhang J X, Song J, Wu D D, et al. Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium [J]. Med Oncol, 2015, 32(4): 101. Krishnan G, Subramaniyan J, Chengalvarayan Subramani P, et al. Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats [J]. Asian J Pharm Sci, 2017, 12(5): 442-455. Zhang J X, Wu D D, Vikash, et al. Hesperetin induces the apoptosis of gastric cancer cells via activating mitochondrial pathway by increasing reactive oxygen species [J]. Dig Dis Sci, 2015, 60(10): 2985-2995. 顾苏平. 橙皮素通过调控Wnt/β-catenin信号通路抑制胃癌细胞AGS的增殖、迁移并诱导其凋亡的实验研究[D]. 南京: 南京中医药大学, 2022. Wang S W, Sheng H, Zheng F, et al. Hesperetin promotes DOT1L degradation and reduces histone H3K79 methylation to inhibit gastric cancer metastasis [J]. Phytomedicine, 2021, 84: 153499. Liang Z F, Xu Y M, Song J J, et al. Interventional effect of hesperetin on N-methyl-N'-nitro-N-nitrosoguanidine-induced exosomal circ008274 in affecting normal cells to promote gastric carcinogenesis [J]. World J Gastroenterol, 2025, 31(16): 104920. He P Z, Ma J J, Liu Y H, et al. Hesperetin promotes cisplatin-induced apoptosis of gastric cancer in vitro and in vivo by upregulating PTEN expression [J]. Front Pharmacol, 2020, 11: 1326. Sun H T. Helicobacter pylori-related serum indicators: Cutting-edge advances to enhance the efficacy of gastric cancer screening [J]. World J Gastrointest Oncol, 2025, 17(3): 100739. Kim H W, Woo H J, Yang J Y, et al. Hesperetin inhibits expression of virulence factors and growth of Helicobacter pylori [J]. Int J Mol Sci, 2021, 22(18): 10035. Mohanad M, El-Awdan S A, Aboulhoda B E, et al. Unraveling the protective effect of hesperetin in experimentally induced colitis: Inhibition of NF-κB and NLRP3 inflammasome activation [J]. J Biochem Mol Toxicol, 2025, 39(3): e70229. Yang L, Gao H, Liu D C. Advance on establishment of pathological model of ulcerative colitis [J]. Front Vet Sci, 2025, 12: 1618260. 孔维姣, 晏乙月, 赵佩凯, 等. 慢性溃疡性结肠炎小鼠疾病活动度、组织病理及细胞因子动态变化分析[J]. 中国比较医学杂志, 2024, 34(6): 18-27. Zhang J X, Lei H B, Hu X, et al. Hesperetin ameliorates DSS-induced colitis by maintaining the epithelial barrier via blocking RIPK3/MLKL necroptosis signaling [J]. Eur J Pharmacol, 2020, 873: 172992. Wang J Z, Yao Y Y, Yao T, et al. Hesperetin alleviated experimental colitis via regulating ferroptosis and gut microbiota [J]. Nutrients, 2024, 16(14): 2343. Chi X S, Chen T, Luo F X, et al. Targeted no-releasing L-arginine-induced hesperetin self-assembled nanoparticles for ulcerative colitis intervention [J]. Acta Biomater, 2024, 190: 560-578. Polat F R, Karaboğa İ. Immunohistochemical examination of anti-inflammatory and anti-apoptotic effects of hesperetin on trinitrobenzene sulfonic acid induced colitis in rats [J]. Biotech Histochem, 2019, 94(3): 151-158. He W, Liu M Y, Li Y M, et al. Flavonoids from Citrus aurantium ameliorate TNBS-induced ulcerative colitis through protecting colonic mucus layer integrity [J]. Eur J Pharmacol, 2019, 857: 172456. Elhennawy M G, Abdelaleem E A, Zaki A A, et al. Cinnamaldehyde and hesperetin attenuate TNBS-induced ulcerative colitis in rats through modulation of the JAK2/STAT3/SOCS3 pathway [J]. J Biochem Mol Toxicol, 2021, 35(5): e22730. Aranganathan S, Nalini N. Efficacy of the potential chemopreventive agent, hesperetin (Citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis [J]. Food Chem Toxicol, 2009, 47(10): 2594-2600. Aranganathan S, Panneer Selvam J, Sangeetha N, et al. Modulatory efficacy of hesperetin (Citrus flavanone) on xenobiotic-metabolizing enzymes during 1,2-dimethylhydrazine-induced colon carcinogenesis [J]. Chem Biol Interact, 2009, 180(2): 254-261. 何佩宜, 郭漫儿, 郑仕伟, 等. 橙皮素对水浸束缚应激小鼠空肠损伤的保护作用研究[J]. 江汉大学学报: 自然科学版, 2025, 53(5): 61-69. 吴静峰. 柑橘来源的类黄酮化合物在结直肠肿瘤的防治和放射性肠损伤的保护效应及机制研究[D]. 重庆: 陆军军医大学, 2023. 谭舒舒, 陈海芳, 罗小泉, 等. 枳壳中芸香柚皮苷和橙皮苷配伍对正常小鼠小肠推进作用的影响[J]. 江西中医药大学学报, 2017, 29(4): 73-75.
PDF下载
全屏
29
11
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
